Execute Robust Analytical & Process Development Strategies for Complex Gene Therapies
Event Dates
2024-10-30 - 2024-11-01
Venue
Organizer
Exhibitors
25
Floor Size
0
Attendees
250
Event contact title
Contact
Event contact first name
.
Event contact last name
.
Email
info@hansonwade.com
Event contact telephone number
UK: +44 (0)20 3141 8700 / US: +1 617 455 4188
Description
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development methods, assess their readiness, and ultimately guarantee safety, quality, efficacy, and consistency of gene therapies to regulators.